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Effect of Age on Immune Function in
Terms of Chemically Induced Cancers
by Michael Bennett*
Neonatal, fetal, and very old animals are particularly sensitive to chemical carcinogenesis. Reasons for
this increased sensitivity could be due to increased susceptibility of "target" organs or cells, peculiar
hormonal levels at these age groups, relatively deficient immune functions, or combinations of these
and/or other factors. During the late fetal and first three weeks of neonatal life, the immune system is
rapidly maturing, is relatively incompetent, and its diverse components are developing at different rates.
For example, thymus-dependent (T) alloreactive cells capable of proliferating in mixed lymphocyte reac-
tions (T helper cells) develop by 7 days of age, but precursors of T killer cells are not competent until
approximately 14 days of age. Bursa equivalent-dependent (B) cells capable of generating antibody
responses are present in fetal liver but are extremely sensitive to tolerance induction until 10-14 days of
age when IgD cell surface receptors are detectable. Marrow-dependent (M) cells responsible for regula-
tionofsuppressor cells and for natural cytotoxicity to transformed tumor cells do not mature until 3 weeks
ofage. In very old animals, the thymus is atrophic and cell-mediated immunity is moderately suppressed.
Natural cytotoxicity against tumor cells is less than normal but antibody formation (B cell function) is
adequate.
Gonadotrophic hormones of the pituitary or placenta are high during pregnancy, the early neonatal
period, after the menopause, and in a large fraction of men over 60 years of age. These and other
hormones are immunosuppressive and could theoretically facilitate carcinogenesis. The particular im-
mune cell type, ifany, responsible for resistance to chemically induced tumors has not been determined.
One can only state that susceptibility tochemical carcinogenesis is associated with a relative dysfunction of
the immune system and that age is an important factor.
Introduction
Chemical carcinogens and even chemical tumor-
promoting agents result in a higher frequency of
tumors with shorter latency periods when adminis-
tered transplacentally to fetuses and during the
neonatal period (1-5). The occurrence of spontane-
ous tumors and susceptibility to tumor induction is
also increased in old age (6, 7). I will describe high-
lights of what is known about the effect of age on
immune function in this review and how this may
relate to the age-associated susceptibility to chemi-
cally induced cancers.
Ontogeny of the Immune
Response
Myelopoietic System
Totipotential hemopoietic stem cells are first de-
tected in the yolk sacs ofdeveloping mice on about
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the eighth day ofa 21-day gestation period (8). Yolk
sac stem cells, when transplanted into lethally ir-
radiated adult mice, differentiate into hemopoietic
cell types seen in adult mice, not fetuses (8).
Therefore, the hemopoietic inductive microenvi-
ronment (9) differs in the developing animal and
regulates the mode of differentiation of stem cells.
For example, granulocytes far outnumber macro-
phages in adult mice but are produced only in small
numbers by the fetus. The yolk sac secretes a
"colony-stimulating factor" (CSF) which acts on a
myeloid precursor to induce differentiation into
macrophages primarily (10). In adult mice, CSF
produced primarily by macrophages (11), induces
differentiation of the same precursor cell primarily
into granulocytes (10). Thus, two events must occur
before "maturation" of a hemopoietic function oc-
curs: the stem cell or precursor cell must be pro-
duced and the hemopoietic "environment" (cell-
to-cell or humoral factor) must be appropriate.
Regulation of erythropoietic differentiation is
under similar control. During gestation, fetal
hemoglobin is produced, but shortly after birth
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occurs (12). The erythropoietic hormone, eryth-
ropoietin, is activated by reticuloendothelial cells of
the liver until two weeks after birth when renal
glomerular cells take over that function (13).
The "'immune" function of the myelopoietic
system includes phagocytosis, antibody-dependent
cellular cytotoxicity and lysis of tumor cells by
non-specifically "'activated" or "armed" macro-
phages. The first line of host defense against most
extracellular bacteria involves phagocytosis and
lysis by granulocytes. This function reaches the
"'adult" level by about 11 days of age in a rep-
resentative experiment (14). The development of
macrophage functions in host defenses appears to
depend upon the organism tested. For example,
macrophages capable of defense against Brucella
abortis are mature by the first week of life (15),
whereas macrophages which protect against Herpes
simplex virus-I hepatitis are immature at 3 weeks of
age and do not mature completely until 8 weeks of
age (16).
Cells with Fc receptors potentially capable of
mediating antibody-dependent cellular cytotoxicity
(ADCC) are present in the yolk sac and placenta of
mice (17) and could presumably lyse antibody-
coated tumor cells. In humans ADCC is not normal
until 3-12 months ofage (18). No age-related studies
of "arming" of macrophages by stimulated lym-
phocytes have been performed.
Lymphoid System
The thymus gland undergoes organogenesis in the
first trimester of human gestation (19). Lympho-
cytes ofthe thymus were thought to be derived from
migrant stem cells from the yolk sac, although re-
cently evidence for an ""embryonic" source has
been obtained (20, 21). The thymus is the central
lymphoid organ for cells involved as ""helper cells"
(TH) in both humoral and cellular immunity, as
"killer cells" (TK) in cellular immunity and as "'sup-
pressor cells" (Ts) in humoral and cellular immu-
nity. TK cells have been shown by numerous inves-
tigators to lyse tumor cells and are ofpotential great
importance in "immunological surveillance"
against chemically induced cancers (19).
When cells are taken from animals and tested in
vitro or in vivo by adoptive transfer into irradiated
adult recipients, TH cells capable of functioning in
humoral antibody responses were detected by 4
days of age (22). TH cells capable of responding
(proliferative component of cellular immunity) to
H-2 allogeneic cells in vivo or in vitro, as above,
were detected within 7 days after birth (23, 24). TK
cells capable oflysing allogeneic target calls afterin
vitro stimulation in cell-mediated lympholysis
(CML) assays are detectable by 14 days ofage. Op-
timal results are obtained in the CML system by
collaboration between TK and TH cells responding to
different types of transplantation antigens (25); it
has not been determined if precursors of TK are
lacking in spleens of mice less than 2 weeks of age
or ifTK-TH cell interactions are suboptimal.
Suppressor cells for antibody reactions are quite
abundant in spleens of neonatal mice (26-28). At
least some of these suppressors are Ts cells, since
they can be inhibited to some extent by antibodies
directed against antigens restricted to T cells. Ts
cells could explain the ease with which transplanta-
tion tolerance can be induced in neonatal mice (29).
After 3 weeks ofage, suppressor cells no longer are
so easily detected. We have detected Ts susceptible
to activation by Friend leukemia virus in neonatal
mice (30). Human cord blood cells can suppress the
response of maternal lymphocytes in vitro (31).
Using intact animals or fetuses to detect immune
reactions, graft-versus-host reactions by adult lym-
phocytes can occur in embryonic chickens (32),
whereas antibody responses are not detectable.
Mice (especially C57BL-strain) can reject skin al-
lografts applied during the first few days oflife (33).
However, Fl hybrid mice less than three weeks of
age are highly susceptible to lethal graft-versus-host
reactions induced by parental-strain lymphoid cells
(34).
The mammalian equivalent of the bursa of Fab-
riscius has not been determined; the central lym-
phoid organ for B cells is definitely not the bone
marrow (35). B cells are first detected in the fetal
liver of mice and B cells capable of generating an-
tibodies upon cell transfer are detectable at 17 days
of gestation in the mouse (22). However, TH + B
cell collaboration on cell transfer is not mature until
6 days after birth. The sequence of immunoglobu-
lins secreted during ontogeny is IgM, IgG and IgA
in most species studied (36). The cell surface Ig re-
ceptors for antigen also undergo a sequence from
IgM to IgM + IgD to IgD + IgG to IgG (37). The B
cells do not have surface IgD until 10-14 days of
age; prior to that time, B cells are extremely sus-
ceptible to tolerance induction in vitro. Acquisition
of IgD makes B cells less easily tolerized. In a re-
cent study, IgE antibody responses were demon-
strable in two-week old mice whereas IgM and IgG
responses were delayed to the same antigen (38).
Mice less than three weeks ofage not competent for
certain humoral and cell-mediated immune reac-
tions (39), and are susceptible to tolerance induction
(29). This is due in part to intrinsic susceptibility of
B cells to tolerance, frequency or numbers of re-
sponsive B cells (40), and an abundance ofsuppres-
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Marrow-dependent (M) cells are a class of im-
mune cells peculiarly dependent upon the integrity
of the marrow microenvironment for their differ-
entiation (35). Treatment of mice with 89Sr, a long-
lived bone-seeking isotope that emits high-energy
beta rays, results in aplastic bone marrow. The
spleen takes over stem cell functions of the mouse
and generates T cells, B cells, macrophages and
myeloid cells. Certain immune functions are absent
and suppressor cells are increased in number (30,
35). The numbers of natural killer (NK) cells capa-
ble of lysing tumor cells (particularly hemopoietic
tumors) are decreased in adult mice treated with
89Sr (41). Such mice are incapable of rejecting
hemopoietic allografts (35) and C57BL mice treated
with 89Sr lose their genetic resistance to leukemia
induction and immunosuppression induced by
Friend virus (30). Mice treated with 89Sr are also
more sensitive to infection with the intracellular or-
ganisms, Herpes simplex-l virus and Listeria
monocytogenes (14, 42). M cells do not mature until
3 weeks of age; their functional maturity is as-
sociated with a decrease in the numbers ofsuppres-
sor cells capable of inhibiting antibody responses
(28) and capable of mediating Friend virus induced
immunosuppression (30). Mice develop resistance
to leukemia virus at 3 weeks ofage when M cells are
functionally mature (30). M cell functions (e.g., NK
cell function) are increased in nude mice (43),
suggesting that Ts cells may inhibit M cells.
The overall balance between various T cell sub-
populations results in an increased susceptibility of
athymic "nude" mice to polyoma virus induced
tumors (44) but no increased susceptibility to
methyl cholanthrene induced skin tumors (45).
Nude mice have an increased "'natural resistance"
to certain infections (46), presumably due to an in-
creased number of "activated macrophages" and
have "tumoricidal macrophages" (47). The mac-
rophages are not "'activated" if nude mice are
germ-free, a finding which suggests that low-grade
infections may be beneficial (48).
Aging of the Immune Response
Myelopoietic System
Hemopoietic stem cells serially transplanted into
lethally irradiated mice undergo cellular "aging"
and lose the ability to protect irradiated mice. The
mechanism of this decline in stem cell function is
excessive demands on the stem cell for differentia-
tion (49). However, myelopoietic stem cells ofmice
not subjected to such extreme demands for
hemopoiesis are functionally competent in aged
mice (12). Aged individuals are particularly suscep-
tible to fatal bacterial pneumonias following viral
infections (50). Conceivably, opsonic phagocytosis
is impaired in old age. Carbon particle clearance is
deficient in old rats (51).
Lymphoid System
The thymus begins to involute shortly after sex-
ual development at puberty and steadily decreases
in size, number of lymphocytes, and content of the
thymic hormones (52, 53). Thymus-dependent anti-
body responses, mitogenic responses to phyto-
hemagglutinin and Concanavalin A and responses
to allogeneic cells in mixed lymphocyte cultures de-
cline at approximately the same rate with time after
puberty (54, 55). However, the decline of T cell
functions have been primarily detected in the
spleen. Lymph node T cell functions remain vigor-
ous even in aging autoimmune strain NZB mice
(56). Splenectomy actually prolonged the life of
mice in one study (57). The loss of T suppressor
cells with age is thought to contribute to the high
incidence of autoantibodies detectable in the aged
population (52). The relatively greater loss of cer-
tain subpopulations ofT cells is thought to also be a
contributing factor for the increased incidence of
tumors with advancing age (58). However, whereas
there was a 4-fold decline in cell-mediated immune
function in old mice, there was a 100-fold loss of
resistance to allogeneic tumor cells (59). Thus,
otherfactors may be more important than effectorT
cells.
There appears to be a relative increase in
phagocytic accessory cells in spleens of old mice
and this could lead to the observed inability to re-
spond to low doses ofantigenic stimulation (54, 58).
Accessory cells do not lose the capacity to interact
with T and B cells in antibody responses with age
(60).
B cell functions do not deteriorate with age but
autoantibodies are produced by B cells in old age
(52). The consensus ofopinion is that loss ofT,. cells
is responsible for this phenomenon. However, au-
toimmune potential appears to reflect a marrow
stem cell abnormality (60) that is corrected by nor-
mal marrow but not by normal thymus cells (Jane I.
Morton, personal communications). It is therefore
conceivable that B cell "'excesses" may contribute
to the increased susceptibility of old animals to
tumors. Splenic B suppressor cells do accumulate
with age (61).
Marrow-dependent (M) cell functions have not
been well investigated in old animals. The ability to
reject marrow cell allografts is present in aged mice
(unpublished observations). However, the func-
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cline sharply after 8 weeks of age. The peak of ac-
tivity is detected between 5 and 8 weeks ofage (45,
62). NK cell function is therefore declining while T
and B cell functions (humoral and cellular immu-
nity) have not yet fully matured! The M cell-
mediated genetic resistance of C57BL mice to the
leukemogenic and immunosuppressive effects of
Friend virus persists for many months of age (un-
published observations). The appearance of sup-
pressor cells for the mixed lymphocyte reaction in
aging mice is under genetic control and the C57BL
mice are "resistant" to the appearance ofsuch sup-
pressor cells (55).
Endocrine Status with Respect to
Age and Immunity
The relationship between the endocrine status
and immunity and tumor susceptibility deserves
examination, particularly since transplacental car-
cinogenesis is so "effective" and the hormone
status is so perturbed during pregnancy. During
pregnancy in humans, there is a dramatic increase
in the level of chorionic gonadotrophic hormones
during the first trimester when the allogeneic blas-
tocyst is implanting itselfand when organogenesis is
occurring rapidly (63). Chorionic gonadotrophins
are immunosuppressive (64-66). Many chemical
carcinogens are immunosuppressive (19), and the
combination of hormones and carcinogen could be
quite immunosuppressive. The direct-acting car-
cinogen 1-ethyl-1-nitrosourea (ENU) is particularly
efficient when administered to Erythrocebus patas
monkeys during the first trimester (67). Other hor-
mones increased during pregnancy, e.g., cortisol
and progesterone, are immunosuppressive (68, 69).
The host endocrine status can influence the suscep-
tibility of mice to chemical carcinogens and certain
carcinogens can affect the endocrine status (70).
The ontogeny of the endocrine system could be al-
tered by the induction of immunological transplan-
tation tolerance in neonatal mice not subjected to a
graft-versus-host reaction (71). Thus, the endocrine
and immune system may be closely controlled. A
gene regulating testosterone metabolism is linked to
the major histocompatibility complex (H-2) of the
mouse (72). Finally, during differentiation of T
cells, the ability to recognize "self" versus "'non-
self" with respect to the ability to respond normally
to virus infections is determined by the thymic
epithelial cells and not other cells ofthe body (73).
These epithelial cells are the source of the thymic
hormones.
In aging humans, there is an increase in gonado-
trophins after the menopause and in a fraction of
men over 60 years of age (63). The hypothalamic
threshold to feedback control is increased with age
(74) and this may contribute to endocrine (and im-
mune?) abnormalities. The pituitary begins to se-
crete a hormone at puberty that inhibits target cell
responses to hormones (51) and could help mediate
immune deficiency in old age.
In summary, one can state that susceptibility to
chemical carcinogenesis is associated with relative
dysfunctions of the immune system and that age is
important because it affects immune function. The
effect could be indirect, mediated by hormonal in-
fluences. This could explain the high frequency of
tumors induced in offspring by carcinogens ad-
ministered during pregnancy and the occurrence of
tumors in the aged.
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